Allurion Technologies
Allurion was founded in 2009 with one mission: end obesity.
Allurion was founded in 2009 with one mission: end obesity.
Allurion Technologies is a healthcare startup that was founded in 2009 with the mission to "end obesity." The company's innovative approach, the Allurion Program, integrates medical, digital, and nutritional methods to assist individuals in kick-starting their weight loss journey and adopting lifelong healthy habits. Having made a significant impact, with over 100,000 balloons placed and over 1,000,000kg lost worldwide, Allurion has already assisted thousands of people in achieving their weight loss goals and transforming their lives. The company is headquartered in the United States. Notably, Allurion secured a $48.00M Post-IPO Debt investment from Fortress Investment Group on 17 April 2024, showcasing continued investor interest and confidence in the company's mission and potential.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $20.00M | 1 |
|
28 Jun 2024 |
| Post-IPO Debt | $48.00M | 1 |
|
17 Apr 2024 |
| Post-IPO Equity | $122.51K | - | 21 Dec 2023 | |
| Series D | $34.00M | 3 |
|
01 Jul 2021 |
| Debt Financing | $25.00M | 2 |
|
06 Apr 2021 |
No recent news or press coverage available for Allurion Technologies.
We care about your data, and we'd love to use cookies make your experience better.
